| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Curis Inc (NASDAQ: CRIS)
CRIS Technical Analysis
5
| As on 9th Jun 2023 CRIS SHARE Price closed @ 0.79 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.72 & Strong Sell for SHORT-TERM with Stoploss of 3.64 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CRISSHARE Price
| Open | 0.83 | Change | Price | % |
| High | 0.83 | 1 Day | -0.03 | -3.66 |
| Low | 0.79 | 1 Week | 0.01 | 1.28 |
| Close | 0.79 | 1 Month | 0.00 | 0.00 |
| Volume | 205800 | 1 Year | -4.09 | -83.81 |
| 52 Week High 5.18 | 52 Week Low 0.47 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CRIS Daily Charts |
CRIS Intraday Charts |
Whats New @ Bazaartrend |
CRIS Free Analysis |
|
|
CRIS Important Levels Intraday
| RESISTANCE | 0.87 |
| RESISTANCE | 0.84 |
| RESISTANCE | 0.83 |
| RESISTANCE | 0.81 |
| SUPPORT | 0.77 |
| SUPPORT | 0.75 |
| SUPPORT | 0.74 |
| SUPPORT | 0.71 |
CRIS Forecast April 2024
| 4th UP Forecast | 2.89 |
| 3rd UP Forecast | 2.22 |
| 2nd UP Forecast | 1.8 |
| 1st UP Forecast | 1.38 |
| 1st DOWN Forecast | 0.2 |
| 2nd DOWN Forecast | -0.22 |
| 3rd DOWN Forecast | -0.64 |
| 4th DOWN Forecast | -1.31 |
CRIS Weekly Forecast
| 4th UP Forecast | 1.77 |
| 3rd UP Forecast | 1.46 |
| 2nd UP Forecast | 1.26 |
| 1st UP Forecast | 1.07 |
| 1st DOWN Forecast | 0.51 |
| 2nd DOWN Forecast | 0.32 |
| 3rd DOWN Forecast | 0.12 |
| 4th DOWN Forecast | -0.19 |
CRIS Forecast2024
| 4th UP Forecast | 10.04 |
| 3rd UP Forecast | 7.07 |
| 2nd UP Forecast | 5.24 |
| 1st UP Forecast | 3.41 |
| 1st DOWN Forecast | -1.83 |
| 2nd DOWN Forecast | -3.66 |
| 3rd DOWN Forecast | -5.49 |
| 4th DOWN Forecast | -8.46 |
Curis Inc ( NASDAQ USA Symbol : CRIS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CRIS Business Profile
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase Ia/Ib clinical trial in patients with solid tumors. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas; and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Address: Building C, Lexington, MA, United States, 02421
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service